Persistent episomal transgene expression in liver following delivery of a scaffold/matrix attachment region containing non-viral vector
- 17 July 2008
- journal article
- research article
- Published by Springer Science and Business Media LLC in Gene Therapy
- Vol. 15 (24), 1593-1605
- https://doi.org/10.1038/gt.2008.113
Abstract
An ideal gene therapy vector should enable persistent transgene expression without limitations of safety and reproducibility. Here we report the development of a non-viral episomal plasmid DNA (pDNA) vector that appears to fulfil these criteria. This pDNA vector combines a scaffold/matrix attachment region (S/MAR) with a human liver-specific promoter (α1-antitrypsin (AAT)) in such a way that long-term expression is enabled in murine liver following hydrodynamic injection. Long-term expression is demonstrated by monitoring the longitudinal luciferase expression profile for up to 6 months by means of in situ bioluminescent imaging. All relevant control pDNA constructs expressing luciferase are unable to sustain significant transgene expression beyond 1 week post-administration. We establish that this shutdown of expression is due to promoter methylation. In contrast, the S/MAR element appears to inhibit methylation of the AAT promoter thereby preventing transgene silencing. Although this vector appears to be maintained as an episome throughout, we have no evidence for its establishment as a replicating entity. We conclude that the combination of a mammalian, tissue-specific promoter with the S/MAR element is sufficient to drive long-term episomal pDNA expression of genes in vivo.Keywords
This publication has 50 references indexed in Scilit:
- Establishment and mitotic stability of an extra-chromosomal mammalian repliconBMC Cell Biology, 2007
- An S/MAR-based infectious episomal genomic DNA expression vector provides long-term regulated functional complementation of LDLR deficiencyNucleic Acids Research, 2007
- Genetically modified pigs produced with a nonviral episomal vectorProceedings of the National Academy of Sciences of the United States of America, 2006
- Improved Production and Purification of Minicircle DNA Vector Free of Plasmid Bacterial Sequences and Capable of Persistent Transgene ExpressionIn VivoHuman Gene Therapy, 2005
- Transcriptional silencing is associated with extensive methylation of the CMV promoter following adenoviral gene delivery to muscleThe Journal of Gene Medicine, 2004
- LMO2 -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1Science, 2003
- Progress and problems with the use of viral vectors for gene therapyNature Reviews Genetics, 2003
- A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined ImmunodeficiencyNew England Journal of Medicine, 2003
- Translating the Histone CodeScience, 2001
- An araC-controlled Bacterialcre Expression System to Produce DNA Minicircle Vectors for Nuclear and Mitochondrial Gene TherapyPublished by Elsevier BV ,2001